Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price

(AJANTPHARM)

Mid Cap

Healthcare Sector

₹2623.2▲2.25%

as on 04:02PM, 15 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Ltd Performance

  • Day's Low

    Day's High

    ₹2,602.1
    Day's Price Range
    ₹2,650.2

  • 52 Week's Low

    52 Week's High

    ₹2,051.6
    52-Week Price Range
    ₹3,485
1 Month Return-0.44 %
3 Month Return-10.95 %
1 Year Return+ 21.14 %
Previous Close₹2,565.40
Open₹2,619.90
Volume77.04K
Upper Circuit₹3,078.40
Lower Circuit₹2,052.40
Market Cap₹32,044.95Cr

Ajanta Pharma Ltd Fundamentals

P/E Ratio

35.87

PEG Ratio

2.71

Market Cap

₹32,044.95 Cr

P/B Ratio

8.28

EPS

64.6

Dividend Yield

2.29

Sector

Pharmaceuticals

ROE

24.24

Ajanta Pharma Ltd Analyst Rating

based on 12 analysts

BUY

66.67%

Buy

8.33%

Hold

25.00%

Sell

Based on 12 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹3011.58

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share analysis

Ajanta Pharma Ltd price forecast by 12 analysts

Upside of17.39%

High

₹3667

Target

₹3011.58

Low

₹2288

Ajanta Pharma Ltd target price ₹3011.58, a slight upside of 17.39% compared to current price of ₹2623.2. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Key events for Ajanta Pharma Ltd

  • Jefferies Initiates Buy on Ajanta Pharma Stock - 15 Apr, 2025

    Jefferies has initiated coverage on Ajanta Pharma with a Buy rating and a target price of ₹2,850, citing strong growth potential in branded generics markets. The firm forecasts a 19% PAT CAGR from FY25 to FY27, highlighting Ajanta's competitive advantages and consistent revenue growth.

  • Ajanta Pharma Projected for 12% Upside by Axis Capital - 24 Mar, 2025

    Axis Capital initiated coverage on Ajanta Pharma with a target price of Rs 3,050, projecting a 12% upside. The brokerage highlights a robust growth outlook, driven by new launches and strong product portfolio, expecting a 12% CAGR for the India business from FY 2024 to FY 2028.

  • Ajanta Pharma Reports Profit Surge and Expansion Plans - 21 Mar, 2025

    Ajanta Pharma announced plans for a new liquid formulation facility at Pithampur and reported an 11% increase in net profit for Q3 FY25, boosting shares by 10%.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AJANTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.89% to 15.13% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AJANTPHARM stock has moved up by 2.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 216.48 Cr → 232.88 Cr (in ₹), with an average increase of 7.0% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.4% return, outperforming this stock by 29.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 9.26% to 8.86% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.20K Cr → 1.17K Cr (in ₹), with an average decrease of 2.5% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.45% to 7.39% in Mar 2025 quarter

Ajanta Pharma Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,105.15Cr (-)₹1,054.08Cr (↓4.62%)₹1,144.92Cr (↑8.62%)₹1,186.64Cr (↑3.64%)₹1,146.13Cr (↓3.41%)
Net Income₹210.03Cr (-)₹202.72Cr (↓3.48%)₹245.77Cr (↑21.24%)₹216.48Cr (↓11.92%)₹232.88Cr (↑7.58%)
Net Profit Margin19.00% (-)19.23% (↑1.21%)21.47% (↑11.65%)18.24% (↓15.04%)20.32% (↑11.40%)
Value in ₹ crore
Details2021202220232024
Total Assets₹3,532.06Cr (-)₹3,808.64Cr (↑7.83%)₹4,339.09Cr (↑13.93%)₹4,252.44Cr (↓2.00%)
Total Liabilities₹647.08Cr (-)₹639.46Cr (↓1.18%)₹1,092.64Cr (↑70.87%)₹838.87Cr (↓23.23%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹300.88Cr (-)₹466.99Cr (↑55.21%)₹542.34Cr (↑16.14%)₹736.29Cr (↑35.76%)₹735.35Cr (↓0.13%)

Ajanta Pharma Ltd Index Inclusions

BSE Mid-Cap

₹41,489.86

3.02 (▲1215.62%)

S&P BSE 250 LargeMidCap

₹9,988.10

2.46 (▲239.95%)

BSE Healthcare

₹41,271.73

2.16 (▲872.85%)

Nifty MidSmallcap 400

₹17,768.15

3.04 (▲524.35%)

Nifty Midcap 150

₹19,178.50

3.03 (▲564.35%)

S&P BSE 150 MidCap

₹14,446.90

3 (▲421.13%)

NIFTY PHARMA

₹20,912.20

2.2 (▲450.3%)

BSE 500

₹33,482.62

2.5 (▲816.51%)

Nifty 500

₹21,279.40

2.54 (▲526.55%)

S&P BSE 400 MidSmallCap

₹10,821.25

2.96 (▲310.6%)

Nifty LargeMidcap 250

₹14,800.55

2.69 (▲387.6%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Ajanta Pharma Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66.26%
0.00
Foreign Institutions
8.86%
0.00
Mutual Funds
15.13%
0.00
Retail Investors
7.39%
0.00
Others
2.36%
0.00

Ajanta Pharma Ltd Key Indicators

Details20202021202220232024
Return On Assets %15.3418.5118.7113.5519.19
Details20202021202220232024
Book Value Per Share (₹)197.56229.68253.5268.14282.34
Details20202021202220232024
Earning Per Share (₹)35.5550.1355.3446.5464.6
Details20202021202220232024
Return On Equity %19.1725.2823.7817.4224.24

Ajanta Pharma Ltd Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (35.87x)

April 11, 2025

Industry (50.30x)

April 11, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Ajanta Pharma Ltd Earnings and Dividends

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 10.88% since last year same period to ₹232.88Cr in the Q3 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated 7.58% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28 - translating a dividend yield of 2.06%.

    Read More about Dividends

Ajanta Pharma Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ajanta Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Ajanta Pharma Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Ajanta Pharma Ltd
Ajanta Pharma Ltd
BUY₹32,044.95 Cr34.61%0.51₹816 Cr₹4,208 Cr
Sanofi India Ltd
Sanofi India Ltd
BUY₹14,277.68 Cr-3.51%0.52₹602 Cr₹2,851 Cr
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹63,424.92 Cr22.06%0.56₹3,168 Cr₹29,001 Cr
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
HOLD₹87,426.64 Cr31.24%0.64₹3,854 Cr₹19,547 Cr
Abbott India Ltd
Abbott India Ltd
BUY₹62,987.34 Cr14.65%0.53NANA
See all

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,146.13Cr as on December 2024 (Q4 24)
Net Profit: ₹232.88Cr as on December 2024 (Q4 24)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Ajanta Pharma Ltd

What is Ajanta Pharma Ltd price today?

Ajanta Pharma Ltd share price today stands at ₹2623.2, Open: ₹2619.9, Previous Close: ₹2565.4, High: ₹2650.2, Low: ₹2602.1, 52 Week High: ₹3485, 52 Week Low: ₹2051.6.

How to Buy Ajanta Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Ajanta Pharma Ltd shares

What are today's traded volumes of Ajanta Pharma Ltd?

Today's traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 77.04K.

What is today's market capitalisation of Ajanta Pharma Ltd?

Today's market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹32044.95Cr.

What is the 52 Week High and Low Range of Ajanta Pharma Ltd?

Ajanta Pharma Ltd (AJANTPHARM)
Price
52 Week High
₹3485
52 Week Low
₹2051.6

How much percentage Ajanta Pharma Ltd is down from its 52 Week High?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2623.2. It is down -24.73% from its 52 Week High price of ₹3485

How much percentage Ajanta Pharma Ltd is up from its 52 Week low?

Ajanta Pharma Ltd (AJANTPHARM) share price is ₹2623.2. It is up 27.86% from its 52 Week Low price of ₹2051.6